St. Johannes Hospital, Eye Clinic, Dortmund, Germany.
Basel University Hospital, Eye Clinic, Basel, Switzerland.
Eur J Ophthalmol. 2021 May;31(3):1405-1412. doi: 10.1177/1120672120914491. Epub 2020 Apr 13.
To estimate a risk-benefit ratio by comparing the efficacy of canaloplasty to trabeculectomy exclusively in pseudophakic eyes with primary open angle glaucoma.
One hundred four eyes that underwent canaloplasty and 136 eyes that underwent trabeculectomy with mitomycin C 0.02% and collagen matrix implantation were retrospectively compared. The efficacy was evaluated by evaluating the absolute success rate (5 ⩽ intraocular pressure ⩽ 15 mmHg) and the qualified success rate (intraocular pressure ⩽15 mmHg) using the Kaplan-Meier survival analysis. A meta-analysis to evaluate the relative risk of both procedures in relation to post-operative interventions was performed.
Mean intraocular pressure was significantly lower in both groups. Intraocular pressure decreased by 32.17% in the canaloplasty group and by 55.04% in the trabeculectomy group at 12 months (analysis of variance, < 0.001). Medication use was lower in both groups (analysis of variance, < 0.001) by the 12th month. The absolute success rate for canaloplasty was 20.19% of eyes compared to 52.21% of eyes with trabeculectomy ( < 0.0001). The qualified success rate was not statistically different between groups ( = 0.15). The relative risk ratio was not statistically different between groups (relative risk of 0.01 and weight of 49.65% for group A and relative risk of 0.0005 and weight of 50.35% for group B; = 0.5). The hospitalization length was longer in trabeculectomy-treated patients (-test, < 0.0001).
The trabeculectomy group showed better results in terms of absolute success rate. However, canaloplasty may provide a better risk-benefit ratio in terms of qualified success rate, hospitalization time, and required post-operative interventions, since canaloplasty yielded equal or superior results compared to trabeculectomy.
通过比较单纯白内障术后原发性开角型青光眼患者行房水引流管植入术与小梁切除术的疗效,评估其风险效益比。
回顾性比较了 104 例接受房水引流管植入术和 136 例接受小梁切除术联合丝裂霉素 C 0.02%和胶原基质植入术的患者。采用 Kaplan-Meier 生存分析评估两组的绝对成功率(5mmHg≤眼压≤15mmHg)和合格成功率(眼压≤15mmHg)。对两种手术术后干预的相对风险进行了荟萃分析。
两组的平均眼压均显著降低。房水引流管植入组眼压在 12 个月时下降 32.17%,小梁切除术组下降 55.04%(方差分析, < 0.001)。两组在第 12 个月时药物使用量均降低(方差分析, < 0.001)。房水引流管植入组的绝对成功率为 20.19%,小梁切除术组为 52.21%( < 0.0001)。两组的合格成功率无统计学差异( = 0.15)。两组间的相对风险比无统计学差异(A 组相对风险为 0.01,权重为 49.65%;B 组相对风险为 0.0005,权重为 50.35%; = 0.5)。小梁切除术组的住院时间较长(t 检验, < 0.0001)。
小梁切除术组在绝对成功率方面的结果更好。然而,从合格成功率、住院时间和术后所需干预措施方面来看,房水引流管植入术可能具有更好的风险效益比,因为其结果与小梁切除术相当或更优。